How to Confirm LBBAP Capture: Procedural, ECG, and Device Evidence
Left Bundle Branch Area Pacing (LBBAP) is increasingly chosen over conventional right-ventricular pacing to preserve physiologic ventricular activation — but how do we actually prove that LBBAP was achieved? The answer lives across three distinct timepoints, each with its own evidence.
What Is a DC-PPM — and How Does It Relate to LBBAP?
DC-PPM stands for Dual-Chamber Permanent Pacemaker: a system with two leads, typically one in the right atrium and one in the ventricle, that senses and paces both chambers to preserve atrioventricular synchrony. This contrasts with single-chamber systems (SC-PPM), leadless pacemakers (e.g., Abbott Aveir VR), CRT biventricular devices, and conduction system pacing configurations.
A common point of confusion: DC-PPM and LBBAP are not competing terms. DC-PPM describes the device configuration (how many leads, which chambers). LBBAP describes a pacing location and strategy (capturing the left bundle branch area to recruit the native conduction system). These dimensions are orthogonal — a DC-PPM can absolutely deliver LBBAP when the ventricular lead is deployed across the interventricular septum to the left bundle branch area.
A modern dual-chamber system with LBBAP preserves AV synchrony (the DC-PPM advantage) and physiologic ventricular activation (the LBBAP advantage). This combination is particularly relevant when upgrading chronic RV-paced patients showing signs of pacing-induced cardiomyopathy.
Layer 1: Intraprocedural Confirmation — The Gold Standard
True LBBAP capture is proven in real time during the implant, with the operator documenting electrophysiologic criteria as the lead is advanced deep into the septum from the RV side.
Paced QRS Morphology in V1
RBBB-like pattern (qR, rSR′, or Qr) reflecting delayed RV activation because the LV depolarizes first via the left bundle — the opposite of LBBB-like RV septal pacing.
V6 R-Wave Peak Time
Short and stable, typically under 75–80 ms. Critically, it should remain constant across high and low outputs — a jump at capture loss suggests only left septal myocardial capture, not true LBB capture.
Output-Dependent Transitions
Demonstrating non-selective → selective LBB capture as output decreases, or LBB capture → LV septal capture loss, is the cleanest physiologic proof of conduction system engagement.
Unipolar Impedance & Injury Current
Lead-tip electrogram findings confirming deep septal penetration, distinct from surface RV septal screw-in.
Fluoroscopy (LAO View)
The lead tracks well into the septum from the RV side rather than resting on the RV septal endocardium, confirming trans-septal depth.
Operator Documentation
The procedure note should explicitly state language such as "LBB capture confirmed," "non-selective to selective LBB capture demonstrated," or "V6 RWPT 72 ms, stable across outputs."
Layer 2: The Post-Implant 12-Lead ECG
Even without access to the procedural tracings, LBBAP can be inferred from the paced ECG with high reliability. Look for this constellation:
- V1: RBBB-like paced morphology — not the LBBB pattern seen with RV apical or septal pacing.
- Paced QRS width: narrow, typically 110–130 ms (conventional RV pacing often exceeds 150 ms).
- Frontal axis: normal — not the left-superior axis characteristic of RV apical pacing.
- V6 R-wave peak time: measurable and short, consistent with rapid LV lateral wall activation.
If the paced QRS on a post-implant ECG shows an LBBB-like morphology with wide QRS and left-superior axis, the lead is pacing the right ventricle — not the left bundle branch area. The device label or implant nomenclature alone does not prove capture.
Layer 3: Device Interrogation and Chest Imaging
The programmer displays a lead-location label (e.g., "LV septal," "LBB area"), but this is a data-entry field reflecting what the operator recorded — not a physiologic measurement. For objective post-hoc confirmation, two imaging sources help:
- Chest X-ray (PA and lateral): on lateral projection, the lead tip sits deep in the mid-septum, pointing leftward and slightly posterior — distinct from an apical or septal RV lead.
- Lead model: the Medtronic 3830 SelectSecure (lumenless, 4.1 Fr) is the workhorse lead for LBBAP. Its presence is suggestive but not diagnostic — the same lead is also used for His bundle pacing and conventional RV septal pacing.
Putting It Together: A Practical Review Workflow
When reviewing a case post-hoc to determine whether true LBBAP was achieved, move through the three layers in sequence:
- Pull the operator's procedure note and search for explicit capture-criterion language (V6 RWPT values, morphology transitions, output-dependent behavior).
- Examine the post-implant 12-lead ECG for RBBB-like V1 morphology and narrow paced QRS with normal axis.
- Correlate with device interrogation data and lateral chest X-ray showing deep septal lead position.
When all three layers align, LBBAP capture is well-supported. When the procedural documentation is thin but the ECG shows unmistakable RBBB-like paced morphology with a narrow QRS, LBBAP capture is likely. When the ECG shows a wide LBBB-like pattern, the lead is almost certainly not capturing the left bundle branch — regardless of what the device label claims.
Bottom Line
LBBAP is a strategy, not a label. Its confirmation requires evidence — ideally procedural capture criteria, reinforced by paced ECG morphology, and corroborated by imaging. For clinicians reviewing their own cases or advocating for an LBBAP upgrade, the cleanest documentation combines all three layers and leaves no ambiguity about whether the conduction system is being recruited or simply approached.